Newfeed

NEW YORK, April 13, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of those who held the common stock of Northern Genesis Acquisition Corp. n/k/a The Lion Electric Company (NYSE: NGA, LEV) as of the record d

Biohaven’s first-in-class Molecular Degrader of Extracellular Proteins (MoDE™) technology targeting IgG removal, BHV-1300, was selected for an oral presentation at AAN highlighting its novel mechanism of action and the latest preclinical data demonstrating rapid, robust, and selective target

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: